ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

August 5, 2005

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985

Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin

July 25, 2013

In Brief: Cancer Center Scientist Set For Space Launch; NIH French Anderson Negotiating With USC

June 5, 1992

Interactive RPGs Deadline Is Feb. 20

December 13, 1991

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997